Gregory M Weinhoff
CIK 1400975 · Chief Business Officer · last filed 2026-03-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.57M
Companies
2
Total Filings
42
Lifetime Open-Market Net
-$6.49M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CNTA | Chief Business Officer | 89,923 | $39.72 | $3.57M | -$5.64M | 35 | 2026-03-26 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Director | 1,928,612 | $14.49 | $27.95M | -$850.0K | 3 | 2008-08-18 |
Recent Filings · Page 4 of 5
42 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-11-23 | CNTA | — | — | $0 | EDGAR |
| 2022-10-04 | CNTA | Sell (S) | −8,901 | -$35.6K | EDGAR |
| 2022-07-06 | CNTA | Grant (A) | +230,000 | $0 | EDGAR |
| 2022-02-03 | CNTA | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | CNTA | Mixed | +10,000 | $200.0K | EDGAR |
| 2018-03-16 | — | Grant (A) | — | $0 | |
| 2017-05-02 | — | Grant (A) | — | $0 | |
| 2016-05-03 | — | Grant (A) | — | $0 | |
| 2015-09-17 | — | Grant (A) | — | $0 | |
| 2008-08-18 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −50,000 | -$850.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.